ESC & iPSC News Volume 17.41 | Oct 26 2022

    0
    119








    2022-10-26 | ESC & iPSC 17.41


    ESC & iPSC News by STEMCELL Technologies
    Vol. 17.41 – 26 October, 2022
    TOP STORY

    Acute Deletion of TET Enzymes Results in Aneuploidy in Mouse Embryonic Stem Cells through Decreased Expression of Khdc3

    Investigators showed that acute deletion of all three Tet genes, after brief exposure of triple-floxed, Cre-ERT2-expressing mESCs to 4-hydroxytamoxifen, resulted in chromosome missegregation and aneuploidy.
    [Nature Communications]

    Full Article
    An ISSCR 2022 Innovation Showcase Webinar: Robust Workflows for the Expansion of PSCs in 3D Suspension Culture, presented by Dr. Eric Jervis. Click to Watch Now.
    PUBLICATIONSRanked by the impact factor of the journal

    ABO Gene Editing for the Conversion of Blood Type A to Universal Type O in Rhnull Donor-Derived Human-Induced Pluripotent Stem Cells

    Researchers presented a CRISPR/Cas9-mediated ABO gene edition strategy for the conversion of blood type A to universal type O, which they had applied to an Rhnull donor-derived hiPSC line, originally carrying blood group A.
    [Clinical and Translational Medicine]

    Full Article

    Human Primed and Naïve PSCs Are Both Able to Differentiate into Trophoblast Stem Cells

    In the absence of WNT stimulation, transforming growth factor β pathway inhibition led to direct and robust conversion of primed human PSCs into trophoblast stem cells.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Generation of Two PITX2 Knock-Out Human Induced Pluripotent Stem Cell Lines Using CRISPR/Cas9 System

    The authors generated two PITX2 knock-out human iPSC lines using CRISPR/Cas9 genome editing. The edited iPSCs maintained full pluripotency, normal karyotype, and spontaneous differentiation capability.
    [Stem Cell Research]

    Full Article

    Generation of a Homozygous and a Heterozygous SNCA Gene Knockout Human-Induced Pluripotent Stem Cell Line by CRISPR/Cas9 Mediated Allele-Specific Tuning of SNCA Expression

    Researchers developed two hiPSC lines using CRISPR/Cas9-mediated allele-specific frame-shift deletion of the aSyn encoding gene SNCA, resulting in homo- and heterozygous SNCA knockout.
    [Stem Cell Research]

    Full Article

    Induced Pluripotent Stem Cells and Cerebral Organoids from the Critically Endangered Sumatran Rhinoceros

    Investigators generated iPSCs from the last male Malaysian Sumatran rhino Kertam, who died in 2019, and characterized them comprehensively.
    [iScience]

    AbstractGraphical Abstract

    Induced Pluripotent Stem Cells of Endangered Avian Species

    Scientists established novel iPSCs from three endangered avian species with seven reprogramming factors.
    [Communications Biology]

    Full Article

    Quantitative Analysis of Transcriptome Dynamics Provides Novel Insights into Developmental State Transitions

    Researchers used transcriptomics to interrogate the process by which pluripotent cells transit to four different lineage-restricted states: neural progenitors, epidermis, endoderm, and ventral mesoderm.
    [BMC Genomics]

    Full Article

    bESC from Cloned Embryos Do Not Retain Transcriptomic or Epigenetic Memory from Somatic Donor Cells

    Investigators applied cutting-edge technologies to analyze the transcriptomic and epigenomic landscape of bovine ESC obtained from in vitro fertilized and somatic cell nuclear transfer embryos.
    [Reproduction]

    Abstract
    ON703PSC-hPSC-genetic-analysis-kit-728x90-1
    REVIEWS

    Elucidating Effects of Environmental Exposure Using Human-Induced Pluripotent Stem Cell Disease Modeling

    The authors suggest that iPSCs and gene-editing techniques can play a pivotal role in elucidating the mechanisms of gene-environment interactions and understanding individual variability in susceptibility to environmental effects.
    [EMBO Molecular Medicine]

    Full ArticleGraphical Abstract

    New Insights into the Epitranscriptomic Control of Pluripotent Stem Cell Fate

    Scientists examine the events driving pluripotent stem cell fate and the underlying changes in gene expression during early development.
    [Experimental & Molecular Medicine]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Harnessing the Potential of Customizable Stem Cells

    New international collaboration between scientists in Canada and Japan aims to accelerate therapies for cancer and other diseases using precisely engineered cells from the patient’s own body.
    [National Research Council Canada]

    Press Release
    FEATURED EVENT

    Cell Culture Engineering XVIII

    April 23 – 28, 2023
    Cancun, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Research Assistant – Cell Culture

    Harvard University – Boston, Massachusetts, United States

    Research Associate – Cell and Molecular Biophysics

    King’s College London – London, England, United Kingdom

    Faculty Positions – Primate Biomedical Research

    Kunming University of Science and Technology – Kunming, China

    Postdoctoral Fellow and Research Associate – Obstetrics and Gynecology

    University of Maryland School of Medicine – Baltimore, Maryland, United States

    Postdoctoral Positions – Organoid Research

    Max Delbrück Center for Molecular Medicine (MDC) – Berlin, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter